Delivery Order SPE2DB22D2206-SPE2DB24FFU21
Award Date 2/26/24
Potential Completion Date 2/27/24
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 20 ml vials of the pharmaceutical product glycopyrrolate 0.2 mg/ml. The total ceiling value of the delivery order is $2,334.12, with a period of performance through April 12, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support...
- This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,341.26, is for the supply of glycopyrrolate 0.2 mg/ml vials (20 ml) to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of May 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4564054211 - Glycopyrrolate 0.2 mg/ml vials in 20 ml sizes. The $1,159.30 delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $5,368.30 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 20 mL vials of Glycopyrrolate 0.2 mg/mL. The delivery order has a period of performance through March 20, 2024. Amerisourcebergen Drug Corp serves as the prime contractor under a $999,999,999.00 indefinite delivery contract awarded by DLA, which represents the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Glycopyrrolate 0.2 mg/ml vial (2 ml) to the DLA, with a ceiling value of $4,806.24 and a performance period through April 22, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,219.16 fixed-price contract is for the supply of glycopyrrolate 1 mg/5 ml vials. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $6,178.82, is for the supply of Glycopyrrolate Injection, a prescription medication. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of glycopyrrolate 0.2 mg/ml vial, 2 ml, a medication used to treat certain medical conditions. The contract has a ceiling value of $4,591.37 and a completion date of July 22, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,872.72 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply glycopyrrolate injectable pharmaceutical products. The order was awarded on July 19, 2023 under an existing indefinite delivery contract held by Amerisourcebergen with no set-aside designation specified. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.93 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Glycopyrrolate 0.2 mg/mL vials. This firm fixed-price, non-set-aside contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal...